Catheter Precision Inc asset turnover ratio, the ability of Catheter Precision Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.06 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as VTAK's position remain challenging.

Within sector 25 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1654 to 1886.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VTAK Asset Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Asset Change	85.3 %	41.47 %	-42.89 %	-4.76 %	-2.66 %
Y / Y Revenue Change	380.66 %	202.1 %	59.73 %	135.42 %	127.96 %
Asset Turnover Ratio (TTM)	0.06	0.04	0.04	0.03	0.02
VTAK's Total Ranking	# 1886	# 1654	# 3284	# 1688	# 1721
Seq. Asset Change	35.01 %	121.22 %	-37.74 %	-0.35 %	3.08 %
Seq. Revenue Change	135.88 %	81.51 %	5.31 %	6.6 %	48.25 %

Asset Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 26
Healthcare Sector	# 91
Overall Market	# 1886

Asset Turnover Ratio Statistics
High	Average	Low
20.81	1.96	-103.06
(Sep 30 2021)		(Jun 30 2022)

VTAK Company Profile • Back to VTAK Efficiency Comparisons • Compare VTAK Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Assets at quarter ending Jun 30 2026
Beam Therapeutics Inc	0.11	$ 156.035 Millions	$ 1,414.853 Millions
Scilex Holding Company	0.11	$ 31.608 Millions	$ 297.014 Millions
Nektar Therapeutics	0.09	$ 54.589 Millions	$ 610.038 Millions
Lipocine Inc	0.08	$ 1.569 Millions	$ 20.568 Millions
Catheter Precision Inc	0.07	$ 1.915 Millions	$ 28.322 Millions
Metagenomi Therapeutics Inc	0.06	$ 13.561 Millions	$ 209.924 Millions
Nurix Therapeutics Inc	0.06	$ 36.766 Millions	$ 595.569 Millions
Ispecimen inc	0.06	$ 0.466 Millions	$ 8.133 Millions
Prophase Labs Inc	0.05	$ 3.150 Millions	$ 60.428 Millions
Insight Molecular Diagnostics Inc	0.05	$ 1.670 Millions	$ 34.891 Millions
Agape Atp Corporation	0.05	$ 1.152 Millions	$ 24.729 Millions
Vistagen Therapeutics Inc	0.04	$ 2.501 Millions	$ 62.393 Millions
Northwest Biotherapeutics Inc	0.03	$ 2.173 Millions	$ 66.973 Millions
Dbv Technologies S a	0.02	$ 5.018 Millions	$ 223.351 Millions
Envoy Medical Inc	0.01	$ 0.207 Millions	$ 17.628 Millions
Bellevue Life Sciences Acquisition Corp	0.01	$ 1.809 Millions	$ 171.835 Millions
Sharps Technology Inc	0.01	$ 2.468 Millions	$ 263.597 Millions
Clene Inc	0.01	$ 0.197 Millions	$ 21.287 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.